US6048729A
(en)
*
|
1987-05-01 |
2000-04-11 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US6544771B1
(en)
|
1987-12-11 |
2003-04-08 |
Cell Genesys, Inc. |
Retroviral gene therapy vectors and therapeutic methods based thereon
|
ATE152169T1
(en)
|
1988-02-05 |
1997-05-15 |
Whitehead Biomedical Inst |
MODIFIED HEPATOCYTES AND THEIR APPLICATION
|
US5580776A
(en)
*
|
1988-02-05 |
1996-12-03 |
Howard Hughes Medical Institute |
Modified hepatocytes and uses therefor
|
US5650148A
(en)
*
|
1988-12-15 |
1997-07-22 |
The Regents Of The University Of California |
Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system
|
US7238673B2
(en)
*
|
1989-03-31 |
2007-07-03 |
The Regents Of The University Of Michigan |
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
|
AU7312891A
(en)
*
|
1990-02-12 |
1991-09-03 |
Board Of Regents, The University Of Texas System |
Satellite cell proliferation in adult skeletal muscle
|
FR2662698A1
(en)
*
|
1990-06-05 |
1991-12-06 |
Centre Nat Rech Scient |
New neurotropic growth factors comprising a homeobox peptide
|
US5269785A
(en)
*
|
1990-06-28 |
1993-12-14 |
Bonutti Peter M |
Apparatus and method for tissue removal
|
US5849572A
(en)
*
|
1990-10-10 |
1998-12-15 |
Regents Of The University Of Michigan |
HSV-1 vector containing a lat promoter
|
US5849571A
(en)
*
|
1990-10-10 |
1998-12-15 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Latency active herpes virus promoters and their use
|
US5618531A
(en)
*
|
1990-10-19 |
1997-04-08 |
New York University |
Method for increasing the viability of cells which are administered to the brain or spinal cord
|
WO1992007945A1
(en)
*
|
1990-10-30 |
1992-05-14 |
Dana Farber Cancer Institute |
Cell type specific alteration of levels of gene products in neural cells
|
JPH05505944A
(en)
*
|
1990-12-26 |
1993-09-02 |
ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ |
Modified hepatocytes and their uses
|
US5800829A
(en)
*
|
1991-04-25 |
1998-09-01 |
Brown University Research Foundation |
Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core
|
DK0585368T3
(en)
|
1991-04-25 |
1998-03-16 |
Univ Brown Res Found |
Implantable biocompatible immuno-insulating vehicle for delivery of selected therapeutic products
|
US6497872B1
(en)
*
|
1991-07-08 |
2002-12-24 |
Neurospheres Holdings Ltd. |
Neural transplantation using proliferated multipotent neural stem cells and their progeny
|
US5981165A
(en)
*
|
1991-07-08 |
1999-11-09 |
Neurospheres Holdings Ltd. |
In vitro induction of dopaminergic cells
|
US5980885A
(en)
*
|
1991-07-08 |
1999-11-09 |
Neurospheres Holdings Ltd. |
Growth factor-induced proliferation of neural precursor cells in vivo
|
US6294346B1
(en)
|
1991-07-08 |
2001-09-25 |
Neurospheres Holdings, Ltd. |
Use of multipotent neural stem cells and their progeny for the screening of drugs and other biological agents
|
US7361505B1
(en)
|
1991-07-08 |
2008-04-22 |
Neurospheres Holdings Ltd. |
Multipotent neural stem cell compositions
|
US6071889A
(en)
*
|
1991-07-08 |
2000-06-06 |
Neurospheres Holdings Ltd. |
In vivo genetic modification of growth factor-responsive neural precursor cells
|
US7166277B1
(en)
*
|
1991-07-08 |
2007-01-23 |
Neurospheres Holdings Ltd. |
Remyelination of neurons using multipotent neural stem cell progeny
|
US6399369B1
(en)
|
1991-07-08 |
2002-06-04 |
Neurospheres Holdings Ltd. |
Multipotent neural stem cell cDNA libraries
|
US5851832A
(en)
*
|
1991-07-08 |
1998-12-22 |
Neurospheres, Ltd. |
In vitro growth and proliferation of multipotent neural stem cells and their progeny
|
US5750376A
(en)
*
|
1991-07-08 |
1998-05-12 |
Neurospheres Holdings Ltd. |
In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny
|
US5329846A
(en)
*
|
1991-08-12 |
1994-07-19 |
Bonutti Peter M |
Tissue press and system
|
US6503277B2
(en)
*
|
1991-08-12 |
2003-01-07 |
Peter M. Bonutti |
Method of transplanting human body tissue
|
US5529774A
(en)
*
|
1991-08-13 |
1996-06-25 |
The Regents Of The University Of California |
In vivo transfer of the HSV-TK gene implanted retroviral producer cells
|
US6214334B1
(en)
*
|
1991-10-21 |
2001-04-10 |
Trustees Of The University Of Pennsylvania |
Compositions and methods for producing and using homogenous neuronal cell transplants to treat neurodegenerative disorders and brain and spinal cord injuries
|
NZ245015A
(en)
|
1991-11-05 |
1995-12-21 |
Transkaryotic Therapies Inc |
Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production
|
US6692737B1
(en)
|
1991-11-05 |
2004-02-17 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US6063630A
(en)
|
1991-11-05 |
2000-05-16 |
Transkaryotic Therapies, Inc. |
Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
|
US6270989B1
(en)
|
1991-11-05 |
2001-08-07 |
Transkaryotic Therapies, Inc. |
Protein production and delivery
|
US5733761A
(en)
|
1991-11-05 |
1998-03-31 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
US6054288A
(en)
*
|
1991-11-05 |
2000-04-25 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
DK0625195T3
(en)
*
|
1991-11-15 |
1999-08-30 |
Univ California |
Treatment of the central nervous system with genetically modified cells
|
WO1993014790A1
(en)
*
|
1992-01-23 |
1993-08-05 |
New York University |
A method for transplanting cells into the brain and therapeutic uses therefor
|
CA2102519A1
(en)
*
|
1992-03-04 |
1993-09-05 |
Jon A. Wolff |
Method of delivering therapeutic substances to the brain
|
US6087323A
(en)
*
|
1992-04-03 |
2000-07-11 |
Cambridge Neuroscience, Inc. |
Use of neuregulins as modulators of cellular communication
|
US5688936A
(en)
*
|
1992-06-11 |
1997-11-18 |
The Regents Of The University Of California |
Vesicle membrane transport proteins
|
WO1994001135A1
(en)
*
|
1992-07-06 |
1994-01-20 |
The Research Foundation Of State University Of New York |
Method of producing genetically modified astrocytes and uses thereof
|
US6670178B1
(en)
|
1992-07-10 |
2003-12-30 |
Transkaryotic Therapies, Inc. |
In Vivo production and delivery of insulinotropin for gene therapy
|
US6531124B1
(en)
|
1992-07-10 |
2003-03-11 |
Transkaryotic Therapies, Inc. |
In vivo production and delivery of insulinotropin for gene therapy
|
US5266588A
(en)
*
|
1992-09-25 |
1993-11-30 |
Bristol-Myers Squibb Company |
Compound produced by a strain of microtetraspora having antibacterial and neuritogenic activity
|
AU692423B2
(en)
*
|
1992-09-25 |
1998-06-11 |
Institut National De La Sante Et De La Recherche Medicale |
Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain
|
US5766948A
(en)
*
|
1993-01-06 |
1998-06-16 |
The Regents Of The University Of California |
Method for production of neuroblasts
|
AU687785B2
(en)
*
|
1993-01-29 |
1998-03-05 |
Neurospheres Holdings Ltd |
Genetic modification of neural stem cells
|
US5753491A
(en)
*
|
1993-04-13 |
1998-05-19 |
Us Health |
Use of neuro-derived fetal cell lines for transplantation therapy
|
PT696205E
(en)
*
|
1993-04-13 |
2002-07-31 |
Us Gov Health & Human Serv |
USE OF NAURO-DERIVED FETAAL CELL LINES FOR TRANSPLANTATION THERAPY
|
FR2704556B1
(en)
*
|
1993-04-30 |
1995-07-13 |
Rhone Poulenc Rorer Sa |
Recombinant viruses and their use in gene therapy.
|
FR2707091B1
(en)
*
|
1993-06-30 |
1997-04-04 |
Cohen Haguenauer Odile |
Retroviral vector for gene transfer and expression in eukaryotic cells.
|
US5908623A
(en)
*
|
1993-08-12 |
1999-06-01 |
Cytotherapeutics, Inc. |
Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
|
EP1179350A3
(en)
*
|
1993-08-12 |
2003-01-02 |
Cytotherapeutics, Inc. |
Encapsulated cell system for implantation into the human CNS
|
DE69431993T2
(en)
*
|
1993-11-09 |
2003-11-27 |
Neurospheres Holding Ltd |
IN SITU MODIFICATION AND MANIPULATION OF STEM CELLS OF THE CENTRAL NERVOUS SYSTEM
|
CA2146735C
(en)
*
|
1994-04-11 |
2007-02-20 |
Chise Tateno |
Liver parenchymal cells having clonal growth ability, method for obtaining same, method for subculturing same, and subculturing system of primary hepatocytes
|
US5714353A
(en)
*
|
1994-05-24 |
1998-02-03 |
Research Corporation Technologies, Inc. |
Safe vectors for gene therapy
|
FR2721943B1
(en)
*
|
1994-06-29 |
1996-08-02 |
Rhone Poulenc Rorer Sa |
ADENOVIRUS COMPRISING A GENE ENCODING A SUPEROXIDE DISMUTASE
|
US5858747A
(en)
*
|
1994-07-20 |
1999-01-12 |
Cytotherapeutics, Inc. |
Control of cell growth in a bioartificial organ with extracellular matrix coated microcarriers
|
US5935849A
(en)
*
|
1994-07-20 |
1999-08-10 |
Cytotherapeutics, Inc. |
Methods and compositions of growth control for cells encapsulated within bioartificial organs
|
US5834029A
(en)
*
|
1994-07-20 |
1998-11-10 |
Cytotherapeutics, Inc. |
Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
|
FR2723588B1
(en)
*
|
1994-08-12 |
1996-09-20 |
Rhone Poulenc Rorer Sa |
ADENOVIRUS COMPRISING A GENE ENCODING GLUTATHIONE PEROXYDASE
|
US6103226A
(en)
*
|
1994-08-12 |
2000-08-15 |
Arch Development Corporation |
Genetically engineered cells that produce produce L. Dopa
|
AU8122094A
(en)
*
|
1994-10-19 |
1996-05-15 |
Human Genome Sciences, Inc. |
Human hypoxanthine-(guanine) phosphoribosyl transferase-2
|
JP2000503521A
(en)
|
1994-11-02 |
2000-03-28 |
トロフィックス ファーマシューティカルズ,インコーポレイテッド |
Peripheral nervous system specific sodium channel, DNA encoding it, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using the same
|
US6277372B1
(en)
*
|
1994-11-08 |
2001-08-21 |
Diacrin, Inc. |
Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases
|
US6204053B1
(en)
|
1994-11-08 |
2001-03-20 |
Diacrin, Inc. |
Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
|
US6294383B1
(en)
|
1994-11-08 |
2001-09-25 |
The Mclean Hospital Corporation |
Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases
|
FR2727429B1
(en)
|
1994-11-30 |
1997-11-28 |
Haguenauer Odile Cohen |
ENCAPSIDATION LINES AND EXPRESSION VECTORS FOR TRANSCOMPLEMENTATION OF DEFECTIVE RETROVIRAL VECTORS
|
EP1006801A4
(en)
*
|
1995-03-13 |
2001-05-02 |
Univ South Florida |
Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders
|
US5702700A
(en)
*
|
1995-03-13 |
1997-12-30 |
University Of South Florida |
Sertoli cells as neurorecovery inducing cells for Parkinson's disease
|
US5681744A
(en)
*
|
1995-03-17 |
1997-10-28 |
Greenstein; Robert J. |
Delivery and expression of heterologus genes using upstream enhancer regions of mammalian gene promoters
|
US6974571B2
(en)
*
|
1995-03-28 |
2005-12-13 |
Thomas Jefferson University |
Isolated stromal cells and methods of using the same
|
US6653134B2
(en)
*
|
1995-03-28 |
2003-11-25 |
Cp Hahnemann University |
Isolated stromal cells for use in the treatment of diseases of the central nervous system
|
US6576607B1
(en)
*
|
1995-04-19 |
2003-06-10 |
Acorda Therapeutics |
Methods using CNS neurite outgrowth modulators
|
AU5390696A
(en)
*
|
1995-04-20 |
1996-11-07 |
University Of South Florida |
Purified and isolated sertoli cell aggregate
|
US5849585A
(en)
*
|
1995-05-10 |
1998-12-15 |
Genetech, Inc. |
Isolating and culturing Schwann cells
|
US5721139A
(en)
*
|
1995-05-10 |
1998-02-24 |
Genentech, Inc. |
Isolating and culturing schwann cells
|
US5714385A
(en)
*
|
1995-05-10 |
1998-02-03 |
Genentech, Inc. |
Media for culturing schwann cells
|
US6033660A
(en)
*
|
1995-05-10 |
2000-03-07 |
Genentech, Inc. |
Method of treating a nervous system injury with cultured schwann cells
|
US6495364B2
(en)
*
|
1995-05-23 |
2002-12-17 |
Neurotech, S.A. |
Mx-1 conditionally immortalized cells
|
WO1996039416A1
(en)
*
|
1995-06-06 |
1996-12-12 |
The Trustees Of The University Of Pennsylvania |
Gene therapy for pituitary adenoma and other endocrine disorders
|
AU742824C
(en)
*
|
1995-06-06 |
2003-03-20 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Use of neuro-derived fetal cell lines for transplantation therapy
|
US6306649B1
(en)
*
|
1995-06-27 |
2001-10-23 |
Ariad Gene Therapeutics, Inc. |
Heterologous transcription factors
|
US5753505A
(en)
*
|
1995-07-06 |
1998-05-19 |
Emory University |
Neuronal progenitor cells and uses thereof
|
US6267955B1
(en)
|
1995-09-15 |
2001-07-31 |
Yeda Research And Development Co. Ltd. |
Mononuclear phagocytes and their use to promote axonal regeneration
|
US5800812A
(en)
*
|
1995-09-15 |
1998-09-01 |
Yeda Research And Development Co. Ltd. |
Methods of use of mononuclear phagocytes to promote axonal regeneration
|
US20020006660A1
(en)
*
|
1996-03-01 |
2002-01-17 |
Rhone-Poulenc Rorer, S.A. |
Genetically-modified neural progenitors and uses thereof
|
AU1979897A
(en)
*
|
1996-03-04 |
1997-09-22 |
University Of Medicine And Dentistry Of New Jersey |
Genetically engineered primary oligodendrocytes for transplantation-mediated gene delivery in the central nervous system
|
FR2746109B1
(en)
|
1996-03-12 |
1998-04-17 |
Rhone Poulenc Rorer Sa |
ENVIRONMENT FOR THE CONSERVATION OF BIOLOGICAL MATERIAL
|
US6037175A
(en)
*
|
1996-03-12 |
2000-03-14 |
The University Of South Florida |
Method and media for enhancing cryopreservation of cells
|
US7544511B2
(en)
*
|
1996-09-25 |
2009-06-09 |
Neuralstem Biopharmaceuticals Ltd. |
Stable neural stem cell line methods
|
US6759499B1
(en)
*
|
1996-07-16 |
2004-07-06 |
Exxonmobil Chemical Patents Inc. |
Olefin polymerization process with alkyl-substituted metallocenes
|
US5718717A
(en)
*
|
1996-08-19 |
1998-02-17 |
Bonutti; Peter M. |
Suture anchor
|
US6713247B1
(en)
|
1996-09-03 |
2004-03-30 |
Signal Pharmaceuticials, Inc. |
Human CNS cell lines and methods of use therefor
|
US20040086494A1
(en)
*
|
1996-10-07 |
2004-05-06 |
John Constance Mary |
Immune privileged cells for delivery of proteins and peptides
|
JP2001513643A
(en)
*
|
1997-03-06 |
2001-09-04 |
ウーベルラ、クラウス |
Vectors and vector systems based on lentivirus
|
US7008765B1
(en)
*
|
1997-04-10 |
2006-03-07 |
The Johns Hopkins University |
PCA3, PCA3 genes, and methods of use
|
IT1292017B1
(en)
*
|
1997-05-28 |
1999-01-25 |
Dompe Spa |
PHARMACEUTICAL COMPOSITIONS CONTAINING MACROPHAGE STIMULATING PROTEIN FOR THE TREATMENT OF NERVOUS SYSTEM PATHOLOGIES
|
JP2002512627A
(en)
*
|
1997-06-11 |
2002-04-23 |
アコーダ セラピーティックス |
CNS nerve regeneration composition and method of using the same
|
US20030121064A1
(en)
*
|
1997-06-11 |
2003-06-26 |
Ann Logan |
CNS neuroregenerative compositions and methods of use
|
AU7963998A
(en)
|
1997-06-13 |
1998-12-30 |
University Technology Corporation |
Transplantation of immortalized dopamine cells to improve neurological deficits
|
WO1999000148A2
(en)
*
|
1997-06-30 |
1999-01-07 |
The Regents Of The University Of California |
Method for treatment of spinal cord injuries in a mammal
|
US6475230B1
(en)
*
|
1997-08-01 |
2002-11-05 |
Peter M. Bonutti |
Method and apparatus for securing a suture
|
US20100081197A1
(en)
*
|
1997-08-14 |
2010-04-01 |
Sylvie Roux |
In vivo modulation of neuronal transport
|
US7923015B2
(en)
*
|
1997-08-14 |
2011-04-12 |
Institut Pasteur |
Methods for direct visualization of active synapses
|
US7923216B2
(en)
*
|
1997-08-14 |
2011-04-12 |
Institut Pasteur |
In vivo modulation of neuronal transport
|
EP1049712B1
(en)
*
|
1997-08-14 |
2007-01-24 |
Institut Pasteur |
Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the cns
|
US5968829A
(en)
*
|
1997-09-05 |
1999-10-19 |
Cytotherapeutics, Inc. |
Human CNS neural stem cells
|
US6093531A
(en)
*
|
1997-09-29 |
2000-07-25 |
Neurospheres Holdings Ltd. |
Generation of hematopoietic cells from multipotent neural stem cells
|
US6045551A
(en)
|
1998-02-06 |
2000-04-04 |
Bonutti; Peter M. |
Bone suture
|
CA2305787A1
(en)
*
|
2000-05-09 |
2001-11-09 |
The University Of British Columbia |
Cxcr4 antagonist treatment of hematopoietic cells
|
CA2245224A1
(en)
*
|
1998-08-14 |
2000-02-14 |
Jiang-Hong Giong |
Chemokine receptor antagonists and chemotherapeutics
|
ATE258444T1
(en)
*
|
1998-03-13 |
2004-02-15 |
Univ British Columbia |
THERAPEUTIC CHEMOKINE RECEPTOR ANTAGONISTS
|
US6815431B2
(en)
|
1998-04-15 |
2004-11-09 |
Regents Of The University Of California |
Methods for therapy of neurodegenerative disease of the brain
|
US7157435B2
(en)
|
1998-04-15 |
2007-01-02 |
The Regents Of The University Of California |
Methods for modulation of the effects of aging on the primate brain
|
US6451306B1
(en)
*
|
1998-04-15 |
2002-09-17 |
The Regents Of The University Of California |
Methods for therapy of neurodegenerative disease of the brain
|
US6683058B1
(en)
|
1998-04-15 |
2004-01-27 |
Regents Of The University Of California |
Methods for therapy of neurodegenerative disease of the brain
|
WO2002007774A2
(en)
*
|
2000-07-19 |
2002-01-31 |
The Regents Of The University Of California |
Methods for therapy of neurodegenerative disease of the brain
|
US6027744A
(en)
*
|
1998-04-24 |
2000-02-22 |
University Of Massachusetts Medical Center |
Guided development and support of hydrogel-cell compositions
|
US6171610B1
(en)
*
|
1998-04-24 |
2001-01-09 |
University Of Massachusetts |
Guided development and support of hydrogel-cell compositions
|
US6593133B1
(en)
|
1998-07-06 |
2003-07-15 |
Nsgene A/S |
Neurotrophic factors
|
WO2000006700A1
(en)
*
|
1998-07-29 |
2000-02-10 |
Layton Bioscience, Inc. |
Production and use of dopaminergic cells to treat dopaminergic deficiencies
|
US6444205B2
(en)
|
1998-09-30 |
2002-09-03 |
Diacrin, Inc. |
Transplantation of neural cells for the treatment of chronic pain or spasticity
|
US7399751B2
(en)
*
|
1999-11-04 |
2008-07-15 |
Sertoli Technologies, Inc. |
Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells
|
US8778899B2
(en)
|
1999-06-01 |
2014-07-15 |
Sarah Ferber |
Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
|
DE19928210B4
(en)
*
|
1999-06-19 |
2005-08-18 |
Neuroprogen Gmbh Leipzig |
Neuronal cell material and method for its production
|
US6447516B1
(en)
|
1999-08-09 |
2002-09-10 |
Peter M. Bonutti |
Method of securing tissue
|
US6368343B1
(en)
|
2000-03-13 |
2002-04-09 |
Peter M. Bonutti |
Method of using ultrasonic vibration to secure body tissue
|
PT1222266E
(en)
|
1999-09-29 |
2006-07-31 |
Diagnocure Inc |
PCA3 MESSENGER RNA IN BENEFICIAL AND MALIGNAL PROSTATE TISSUES
|
US7560275B2
(en)
*
|
1999-12-30 |
2009-07-14 |
Vbi Technologies, L.L.C. |
Compositions and methods for generating skin
|
US7575921B2
(en)
*
|
1999-12-30 |
2009-08-18 |
Vbi Technologies, L.L.C. |
Spore-like cells and uses thereof
|
US6635073B2
(en)
|
2000-05-03 |
2003-10-21 |
Peter M. Bonutti |
Method of securing body tissue
|
US20050059584A1
(en)
*
|
2002-08-16 |
2005-03-17 |
Ahmed Merzouk |
Novel chemokine mimetics synthesis and their use
|
US7368425B2
(en)
*
|
2006-03-24 |
2008-05-06 |
Chemokine Therapeutics Corp. |
Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis
|
US7378098B2
(en)
*
|
2000-04-12 |
2008-05-27 |
The University Of British Columbia |
CXC chemokine receptor 4 agonist peptides
|
CA2335109A1
(en)
*
|
2000-04-12 |
2001-10-12 |
Chemokine Therapeutics Corporation |
Cxcr4 agonist treatment of hematopoietic cells
|
AU2001251599B2
(en)
*
|
2000-04-14 |
2006-03-02 |
University Of Pittsburgh |
Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
|
US7037493B2
(en)
|
2000-05-01 |
2006-05-02 |
Cornell Research Foundation, Inc. |
Method of inducing neuronal production in the brain and spinal cord
|
US6897061B1
(en)
|
2000-06-16 |
2005-05-24 |
Spinal Cord Society |
Transdifferentiation of glial cells
|
JP4031901B2
(en)
*
|
2000-07-19 |
2008-01-09 |
株式会社東芝 |
Solid-state imaging device
|
US20020151050A1
(en)
*
|
2000-10-30 |
2002-10-17 |
Vacanti Charles A. |
Isolation of spore-like cells from tissues exposed to extreme conditions
|
US20060280724A1
(en)
*
|
2000-11-04 |
2006-12-14 |
Ferguson Ian A |
Identification of ligands that enable endocytosis, using in vivo manipulation of neuronal fibers
|
IL155728A0
(en)
*
|
2000-11-22 |
2003-11-23 |
Geron Corp |
Tolerizing allografts of pluripotent stem cells
|
US6576464B2
(en)
*
|
2000-11-27 |
2003-06-10 |
Geron Corporation |
Methods for providing differentiated stem cells
|
US6921665B2
(en)
*
|
2000-11-27 |
2005-07-26 |
Roslin Institute (Edinburgh) |
Selective antibody targeting of undifferentiated stem cells
|
EP1385938A1
(en)
*
|
2001-04-23 |
2004-02-04 |
Nsgene A/S |
Method and culture medium for producing neural cells expressing tyrosine hydroxylase
|
US6719765B2
(en)
|
2001-12-03 |
2004-04-13 |
Bonutti 2003 Trust-A |
Magnetic suturing system and method
|
WO2003070189A2
(en)
*
|
2002-02-15 |
2003-08-28 |
Cornell Research Foundation, Inc. |
Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein
|
AU2003293409A1
(en)
|
2002-12-09 |
2004-06-30 |
Karl K. Johe |
Method for discovering neurogenic agents
|
US8293488B2
(en)
|
2002-12-09 |
2012-10-23 |
Neuralstem, Inc. |
Method for screening neurogenic agents
|
US8551100B2
(en)
|
2003-01-15 |
2013-10-08 |
Biomet Manufacturing, Llc |
Instrumentation for knee resection
|
US7887542B2
(en)
*
|
2003-01-15 |
2011-02-15 |
Biomet Manufacturing Corp. |
Method and apparatus for less invasive knee resection
|
US7789885B2
(en)
*
|
2003-01-15 |
2010-09-07 |
Biomet Manufacturing Corp. |
Instrumentation for knee resection
|
US7837690B2
(en)
*
|
2003-01-15 |
2010-11-23 |
Biomet Manufacturing Corp. |
Method and apparatus for less invasive knee resection
|
ES2427853T3
(en)
|
2003-02-07 |
2013-11-04 |
Diagnocure Inc. |
Procedure to detect prostate cancer in a sample
|
WO2004098621A1
(en)
*
|
2003-04-17 |
2004-11-18 |
U.S. Department Of Veterans Affairs |
Isolated/cloned human nt2 cell lines expressing serotonin and gaba
|
US7459152B2
(en)
*
|
2003-04-23 |
2008-12-02 |
Rush University Medical Center |
Erythropoietin administration to improve graft survival
|
CN103230415B
(en)
*
|
2003-04-25 |
2016-05-04 |
匹兹堡大学联邦制高等教育 |
For promoting and strengthen the neural muscle derived cell (MDC) of repairing and regenerating
|
WO2005018540A2
(en)
*
|
2003-07-03 |
2005-03-03 |
Jannette Dufour |
Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants
|
US7326571B2
(en)
*
|
2003-07-17 |
2008-02-05 |
Boston Scientific Scimed, Inc. |
Decellularized bone marrow extracellular matrix
|
US20050013870A1
(en)
*
|
2003-07-17 |
2005-01-20 |
Toby Freyman |
Decellularized extracellular matrix of conditioned body tissues and uses thereof
|
WO2005033297A1
(en)
*
|
2003-09-19 |
2005-04-14 |
The Rockefeller University |
Compositions, methods and kits relating to reprogramming adult differentiated cells and production of embryonic stem cell-like cells
|
US20050070379A1
(en)
*
|
2003-09-26 |
2005-03-31 |
Todd Gilmour |
Rite-Hite Golf Tee
|
US7488324B1
(en)
|
2003-12-08 |
2009-02-10 |
Biomet Manufacturing Corporation |
Femoral guide for implanting a femoral knee prosthesis
|
KR101204286B1
(en)
|
2004-03-30 |
2012-11-26 |
엔에스진 에이/에스 |
Therapeutic use of a growth factor, NsG33
|
GB2414995B
(en)
|
2004-06-09 |
2006-11-15 |
Univ Edinburgh |
Neural stem cells
|
US20090136552A1
(en)
*
|
2004-07-30 |
2009-05-28 |
Mette Gronborg |
Growth factors nsg28, nsg30, and nsg32
|
KR101429284B1
(en)
|
2004-11-17 |
2014-08-11 |
뉴럴스템, 인크. |
Transplantation of Human Neural Cells for Treatment of Neurodegenerative Conditions
|
US7833513B2
(en)
|
2004-12-03 |
2010-11-16 |
Rhode Island Hospital |
Treatment of Alzheimer's Disease
|
CA2491067A1
(en)
*
|
2004-12-24 |
2006-06-24 |
Stichting Katholieke Universiteit |
Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
|
CA2596281A1
(en)
*
|
2005-01-31 |
2006-08-10 |
Cognate Therapeutics, Inc. |
Adipose derived adult stromal cells exhibiting characteristics of endothelial cells
|
US20070092449A1
(en)
*
|
2005-04-05 |
2007-04-26 |
Rafael Vazquez-Martinez |
Methods for direct visualization of active synapses
|
US7695479B1
(en)
|
2005-04-12 |
2010-04-13 |
Biomet Manufacturing Corp. |
Femoral sizer
|
TW200726474A
(en)
*
|
2005-07-15 |
2007-07-16 |
Cognate Therapeutics Inc |
The immunophenotype and immunogenicity of human adipose derived cells
|
US8926959B2
(en)
|
2005-07-22 |
2015-01-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
System for optical stimulation of target cells
|
US9274099B2
(en)
|
2005-07-22 |
2016-03-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Screening test drugs to identify their effects on cell membrane voltage-gated ion channel
|
US10052497B2
(en)
*
|
2005-07-22 |
2018-08-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
System for optical stimulation of target cells
|
US9238150B2
(en)
*
|
2005-07-22 |
2016-01-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Optical tissue interface method and apparatus for stimulating cells
|
US9278159B2
(en)
|
2005-07-22 |
2016-03-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Light-activated cation channel and uses thereof
|
US20090093403A1
(en)
|
2007-03-01 |
2009-04-09 |
Feng Zhang |
Systems, methods and compositions for optical stimulation of target cells
|
US8357666B2
(en)
*
|
2005-08-01 |
2013-01-22 |
Nupotential, Inc. |
Reprogramming a cell by inducing a pluripotent gene through RNA interference
|
US20070093439A1
(en)
*
|
2005-10-25 |
2007-04-26 |
Idera Pharmaceuticals, Inc. |
Short immunomodulatory oligonucleotides
|
JP5247468B2
(en)
*
|
2005-12-30 |
2013-07-24 |
ニューロテック ユーエスエー, インコーポレイテッド |
Micronized device for delivery of bioactive molecules and method of use thereof
|
US20070178137A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Toby Freyman |
Local control of inflammation
|
US8603180B2
(en)
|
2006-02-27 |
2013-12-10 |
Biomet Manufacturing, Llc |
Patient-specific acetabular alignment guides
|
US9339278B2
(en)
|
2006-02-27 |
2016-05-17 |
Biomet Manufacturing, Llc |
Patient-specific acetabular guides and associated instruments
|
TWI501774B
(en)
|
2006-02-27 |
2015-10-01 |
Biogen Idec Inc |
Treatments for neurological disorders
|
US9345548B2
(en)
|
2006-02-27 |
2016-05-24 |
Biomet Manufacturing, Llc |
Patient-specific pre-operative planning
|
US9918740B2
(en)
|
2006-02-27 |
2018-03-20 |
Biomet Manufacturing, Llc |
Backup surgical instrument system and method
|
US9113971B2
(en)
|
2006-02-27 |
2015-08-25 |
Biomet Manufacturing, Llc |
Femoral acetabular impingement guide
|
US8070752B2
(en)
*
|
2006-02-27 |
2011-12-06 |
Biomet Manufacturing Corp. |
Patient specific alignment guide and inter-operative adjustment
|
US10278711B2
(en)
|
2006-02-27 |
2019-05-07 |
Biomet Manufacturing, Llc |
Patient-specific femoral guide
|
US9173661B2
(en)
|
2006-02-27 |
2015-11-03 |
Biomet Manufacturing, Llc |
Patient specific alignment guide with cutting surface and laser indicator
|
US8591516B2
(en)
|
2006-02-27 |
2013-11-26 |
Biomet Manufacturing, Llc |
Patient-specific orthopedic instruments
|
US7780672B2
(en)
*
|
2006-02-27 |
2010-08-24 |
Biomet Manufacturing Corp. |
Femoral adjustment device and associated method
|
US20150335438A1
(en)
|
2006-02-27 |
2015-11-26 |
Biomet Manufacturing, Llc. |
Patient-specific augments
|
US9289253B2
(en)
|
2006-02-27 |
2016-03-22 |
Biomet Manufacturing, Llc |
Patient-specific shoulder guide
|
US9907659B2
(en)
|
2007-04-17 |
2018-03-06 |
Biomet Manufacturing, Llc |
Method and apparatus for manufacturing an implant
|
US8407067B2
(en)
|
2007-04-17 |
2013-03-26 |
Biomet Manufacturing Corp. |
Method and apparatus for manufacturing an implant
|
US20100030102A1
(en)
*
|
2006-05-15 |
2010-02-04 |
David Poston |
Active Delivery and Flow Redirections: Novel Devices and Method of Delivery of Materials to Patients
|
US7998128B2
(en)
|
2006-05-15 |
2011-08-16 |
Therataxis, LLC. |
Active delivery and flow redirection: novel devices and method of delivery of materials to patients
|
US7695520B2
(en)
*
|
2006-05-31 |
2010-04-13 |
Biomet Manufacturing Corp. |
Prosthesis and implementation system
|
US20110287010A1
(en)
|
2006-06-07 |
2011-11-24 |
Otago Innovation Limited |
Diagnostic methods and markers
|
US9795399B2
(en)
|
2006-06-09 |
2017-10-24 |
Biomet Manufacturing, Llc |
Patient-specific knee alignment guide and associated method
|
US9717775B2
(en)
|
2006-07-18 |
2017-08-01 |
University Of Utah Research Foundation |
Methods for treating pain and screening analgesic compounds
|
WO2008086470A1
(en)
|
2007-01-10 |
2008-07-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
System for optical stimulation of target cells
|
DK2114167T3
(en)
|
2007-01-16 |
2018-09-17 |
Univ Rochester |
NON-HUMAN ANIMALS WITH HUMAN GLIAKIMARY BRAIN
|
WO2008101128A1
(en)
*
|
2007-02-14 |
2008-08-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
System, method and applications involving identification of biological circuits such as neurological characteristics
|
WO2008134406A1
(en)
*
|
2007-04-25 |
2008-11-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Ischemia-induced neovascularization is enhanced by hcns-sc transplantation
|
US10434327B2
(en)
*
|
2007-10-31 |
2019-10-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Implantable optical stimulators
|
US10035027B2
(en)
*
|
2007-10-31 |
2018-07-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Device and method for ultrasonic neuromodulation via stereotactic frame based technique
|
CN102083968A
(en)
|
2008-04-07 |
2011-06-01 |
纽珀滕索有限公司 |
Reprogramming a cell by inducing a pluripotent gene through use of a small molecule modulator
|
JP5801188B2
(en)
|
2008-04-23 |
2015-10-28 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
Systems, methods, and compositions for photostimulating target cells
|
US8729040B2
(en)
*
|
2008-05-29 |
2014-05-20 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cell line, system and method for optical control of secondary messengers
|
MY162929A
(en)
*
|
2008-06-17 |
2017-07-31 |
Univ Leland Stanford Junior |
Apparatus and methods for controlling cellular development
|
CA2728238C
(en)
|
2008-06-17 |
2019-03-12 |
M. Bret Schneider |
Methods, systems and devices for optical stimulation of target cells using an optical transmission element
|
WO2010006049A1
(en)
|
2008-07-08 |
2010-01-14 |
The Board Of Trustees Of The Leland Stanford Junior University |
Materials and approaches for optical stimulation of the peripheral nervous system
|
NZ602416A
(en)
|
2008-11-14 |
2014-08-29 |
Univ Leland Stanford Junior |
Optically-based stimulation of target cells and modifications thereto
|
CN102325878A
(en)
|
2008-12-23 |
2012-01-18 |
斯特姆塞尔思加利福尼亚有限公司 |
Target populations of oligodendrocyte precursor cells and methods of making and using same
|
US9511093B2
(en)
*
|
2009-03-23 |
2016-12-06 |
The Texas A & M University System |
Compositions of mesenchymal stem cells to regenerate bone
|
BRPI0902039B8
(en)
|
2009-06-09 |
2021-05-25 |
Anhanguera Educacional Ltda |
pharmaceutical composition and use of pharmaceutical composition for the treatment, prophylaxis or prevention of neoplastic diseases in humans and animals
|
US8288158B2
(en)
*
|
2009-06-12 |
2012-10-16 |
Board Of Regents, The University Of Texas System |
Stem cells modified to facilitate threonine catabolism
|
CA2780549C
(en)
|
2009-11-12 |
2017-01-03 |
Vbi Technologies, L.L.C. |
Subpopulations of spore-like cells and uses thereof
|
WO2011116238A2
(en)
|
2010-03-17 |
2011-09-22 |
The Board Of Trustees Of The Leland Stanford Junior University. |
Light-sensitive ion-passing molecules
|
AU2011282642B2
(en)
|
2010-07-28 |
2015-06-11 |
Shinn-Zong Lin |
Methods for treating and/or reversing neurodegenerative diseases and/or disorders
|
CN108079279B
(en)
|
2010-10-01 |
2022-04-12 |
霍巴治疗公司 |
Use of nickel-line protein for treating allodynia, hyperalgesia, spontaneous pain and phantom pain
|
AU2011323199B2
(en)
|
2010-11-05 |
2016-01-28 |
The Board Of Trustees Of The Leland Stanford Junior University |
Stabilized step function opsin proteins and methods of using the same
|
CA2817175C
(en)
|
2010-11-05 |
2019-09-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Upconversion of light using lanthanide-doped nanoparticles for use in optogenetic methods
|
CN103476456B
(en)
|
2010-11-05 |
2017-10-03 |
斯坦福大学托管董事会 |
Award the light Genetic control of corelation behaviour
|
US10086012B2
(en)
|
2010-11-05 |
2018-10-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Control and characterization of memory function
|
CN106106368A
(en)
|
2010-11-05 |
2016-11-16 |
斯坦福大学托管董事会 |
Optically-controlledCNS CNS dysfunction
|
EP2635108B1
(en)
|
2010-11-05 |
2019-01-23 |
The Board of Trustees of the Leland Stanford Junior University |
Light-activated chimeric opsins and methods of using the same
|
US8696722B2
(en)
|
2010-11-22 |
2014-04-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Optogenetic magnetic resonance imaging
|
US9968376B2
(en)
|
2010-11-29 |
2018-05-15 |
Biomet Manufacturing, Llc |
Patient-specific orthopedic instruments
|
US9241745B2
(en)
|
2011-03-07 |
2016-01-26 |
Biomet Manufacturing, Llc |
Patient-specific femoral version guide
|
EP2791333B1
(en)
|
2011-12-16 |
2019-03-06 |
The Board of Trustees of the Leland Stanford Junior University |
Opsin polypeptides and methods of use thereof
|
US20140024701A1
(en)
|
2012-02-21 |
2014-01-23 |
Circuit Therapeutics, Inc. |
Compositions and Methods for Treating Neurogenic Disorders of the Pelvic Floor
|
US9636380B2
(en)
|
2013-03-15 |
2017-05-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Optogenetic control of inputs to the ventral tegmental area
|
US9790468B2
(en)
|
2013-03-15 |
2017-10-17 |
Avita Iinternational Ltd. |
Multifunctional immature dental pulp stem cells and therapeutic applications
|
CA2906756A1
(en)
|
2013-03-15 |
2014-09-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Optogenetic control of behavioral state
|
EP2989198A4
(en)
|
2013-04-26 |
2016-10-26 |
Sloan Kettering Inst Cancer |
Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells
|
CA2908864A1
(en)
|
2013-04-29 |
2014-11-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Devices, systems and methods for optogenetic modulation of action potentials in target cells
|
WO2014194284A1
(en)
|
2013-05-31 |
2014-12-04 |
Mcintosh J Michael |
Conotoxin peptides, pharmaceutical compositions and uses thereof
|
US9982236B2
(en)
|
2013-06-13 |
2018-05-29 |
Orgenesis Ltd. |
Cell populations, methods of transdifferentiation and methods of use thereof
|
CN105829538A
(en)
|
2013-08-14 |
2016-08-03 |
小利兰·斯坦福大学托管委员会 |
Silicone-modified polyester coating
|
US10779519B2
(en)
|
2014-05-13 |
2020-09-22 |
University Of Rochester |
Human glial chimeric model for drug candidate assessment in human gliotrophic viral infections and progressive multifocal encephalopathy
|
KR20190060016A
(en)
|
2014-10-20 |
2019-05-31 |
뉴럴스템, 인크. |
Stable neural stem cells comprising an exogenous polynucleotide coding for a growth factor and methods of use thereof
|
MA41296A
(en)
|
2014-12-30 |
2017-11-07 |
Orgenesis Ltd |
TRANSDIFFERENTIATION PROCESSES AND METHODS FOR USING THE SAME
|
US9724432B2
(en)
|
2015-04-30 |
2017-08-08 |
University Of Rochester |
Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
|
WO2016209654A1
(en)
|
2015-06-22 |
2016-12-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and devices for imaging and/or optogenetic control of light-responsive neurons
|
US10722310B2
(en)
|
2017-03-13 |
2020-07-28 |
Zimmer Biomet CMF and Thoracic, LLC |
Virtual surgery planning system and method
|
US11294165B2
(en)
|
2017-03-30 |
2022-04-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modular, electro-optical device for increasing the imaging field of view using time-sequential capture
|
EP3635106A4
(en)
|
2017-05-08 |
2021-01-06 |
Orgenesis Ltd. |
Transdifferentiated cell populations and methods of use thereof
|
US20220062378A1
(en)
|
2018-06-21 |
2022-03-03 |
University Of Rochester |
Methods of treating or inhibiting onset of huntington's disease
|
US20230057355A1
(en)
|
2019-02-13 |
2023-02-23 |
University Of Rochester |
Gene networks that mediate remyelination of the human brain
|
AU2022269279A1
(en)
|
2021-05-06 |
2023-11-30 |
Hoba Therapeutics Aps |
Prevention and treatment of chemotherapy-induced neuropathic pain
|
US20230277600A1
(en)
|
2021-10-20 |
2023-09-07 |
University Of Rochester |
Treatment Of Age-Related White Matter Loss By Competitive Replacement Of Glial Cells
|
WO2023069843A1
(en)
|
2021-10-20 |
2023-04-27 |
University Of Rochester |
Humanized chimeras for the prospective assessment of cell addition and replacement therapies
|
WO2023081633A1
(en)
|
2021-11-02 |
2023-05-11 |
University Of Rochester |
Tcf7l2 mediated remyelination in the brain
|
WO2023104960A1
(en)
|
2021-12-10 |
2023-06-15 |
Hoba Therapeutics Aps |
Treatment of nociceptive pain
|
WO2023215455A1
(en)
|
2022-05-05 |
2023-11-09 |
University Of Rochester |
Dual macroglial-microglial approach towards therapeutic cell replacement in neurodegenerative and neuropsychiatric disease
|